Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2010 | Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance | I-RUE LAI ; TANG-LONG SHEN ; Lin H.-S.; Liou J.-Y.; Jan Y.-J.; JEN-CHIEH LEE | American Journal of Pathology | 52 | 51 | |
2018 | Prognostic significance of 14-3-3ε, aldo-keto reductase family 1 B10 and metallothionein-1 in hepatocellular carcinoma | Wu C.-Y.; Jan Y.-J.; BOR-SHENG KO ; Wu Y.-J.; Wu Y.-J.; Liou J.-Y. | Anticancer Research | 5 | 3 | |
2021 | Reduced expression of metallothionein-i/ii in renal proximal tubules is associated with advanced chronic kidney disease | Lu Y.-J.; Wu Y.-J.; Chen L.-J.; BOR-SHENG KO ; Chang T.-C.; Wu Y.-J.; Liang S.-M.; Jan Y.-J.; Liou J.-Y. | Toxins | 2 | 2 | |
2015 | Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3∈ and their prognostic impact of hepatocellular carcinoma | Liu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Wu Y.-J.; Lu Y.-J.; Liang S.-M.; Liu C.-C.; Chen S.-C.; Wang J.; Shyue S.-K.; Liou J.-Y. | Oncotarget | 18 | 17 | |
2013 | Upregulation of Focal adhesion kinase by 14-3-3ε via NFκB activation in Hepatocellular Carcinoma | BOR-SHENG KO ; Jan Y.-J.; Chang T.-C.; Liang S.-M.; Chen S.-C.; Liu T.-A.; YAO-MING WU ; Wang J.; Liou J.-Y. | Anti-Cancer Agents in Medicinal Chemistry | 28 | 23 | |
2019 | ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma | Wu Y.-J.; BOR-SHENG KO ; Liang S.-M.; Lu Y.-J.; Jan Y.-J.; Jiang S.-S.; Shyue S.-K.; Chen L.; Liou J.-Y. | Cell Death and Disease | 16 | 14 |